As an example, as discussed before, AMPK has a number of beneficial effects in NAFLD, and it is also known to control the expression of PGC-1α by phosphorylation and deacetylation [231]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.